skip to content
  1. Home
  2. >
  3. Questions
  4. >
  5. LLY: Hello 5i team! [Eli Lilly and Company]
You can view 2 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hello 5i team!
You often seem bullish on tri. I know it's grown in the past year and I know you're not fans of analyst predictions, but the one year estimate is about $220.50. can you please explain why this would be a good investment today for the next couple years, and/or offer a couple other better growth ideas? Thanks!
Asked by Vince on August 26, 2024
5i Research Answer:

TRI has historically operated as a holding company. Buying assets, growing them, and at times monetizing them for a profit. Thus, its 'regular' earnings scenario can be hard to forecast sometimes. Currently, it has attractive businesses but also has a very high capacity to make an acquisition Thus, much might happen in the next two years. Consensus calls for about 10% to 15% growth next year. It is one of our favourite 'conservative' growth stocks because of management and its very impressive long term history of good deals. We don't pay too much attention to targets. Looking for example at Goldman Sachs, it had a $45 target price and a SELL rating on TRI in 2017. SHOP, NVDA, LLY will have higher growth but at very different valuations and risk levels. We would not see TRI as a SELL. 

Authors of this answer, directors, partners and/or officers of 5i Research and/or affiliated companies have a financial or other interest in NVDA.